Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: A4H6P4
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006839 | mitochondrial transport | 4 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0007005 | mitochondrion organization | 5 | 1 |
GO:0007006 | mitochondrial membrane organization | 5 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0032978 | protein insertion into membrane from inner side | 6 | 1 |
GO:0032979 | protein insertion into mitochondrial inner membrane from matrix | 5 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0033365 | protein localization to organelle | 5 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051205 | protein insertion into membrane | 5 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0061024 | membrane organization | 4 | 1 |
GO:0070585 | protein localization to mitochondrion | 6 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0072594 | establishment of protein localization to organelle | 4 | 1 |
GO:0072655 | establishment of protein localization to mitochondrion | 5 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
GO:0090151 | establishment of protein localization to mitochondrial membrane | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0032977 | membrane insertase activity | 3 | 12 |
GO:0140104 | molecular carrier activity | 1 | 12 |
GO:0140597 | protein carrier chaperone | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.430 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.252 |
CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.252 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.452 |
CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.252 |
CLV_PCSK_PC1ET2_1 | 171 | 173 | PF00082 | 0.252 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 156 | 160 | PF00082 | 0.252 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.252 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.557 |
CLV_Separin_Metazoa | 80 | 84 | PF03568 | 0.346 |
DOC_CDC14_PxL_1 | 112 | 120 | PF14671 | 0.361 |
DOC_CDC14_PxL_1 | 207 | 215 | PF14671 | 0.263 |
DOC_CYCLIN_RxL_1 | 107 | 117 | PF00134 | 0.424 |
DOC_CYCLIN_yCln2_LP_2 | 185 | 191 | PF00134 | 0.347 |
DOC_CYCLIN_yCln2_LP_2 | 291 | 297 | PF00134 | 0.320 |
DOC_MAPK_FxFP_2 | 306 | 309 | PF00069 | 0.538 |
DOC_MAPK_gen_1 | 247 | 257 | PF00069 | 0.452 |
DOC_MAPK_gen_1 | 83 | 93 | PF00069 | 0.372 |
DOC_MAPK_MEF2A_6 | 262 | 271 | PF00069 | 0.361 |
DOC_MAPK_MEF2A_6 | 86 | 95 | PF00069 | 0.364 |
DOC_PP1_RVXF_1 | 8 | 15 | PF00149 | 0.411 |
DOC_PP2B_LxvP_1 | 185 | 188 | PF13499 | 0.347 |
DOC_PP2B_LxvP_1 | 218 | 221 | PF13499 | 0.242 |
DOC_PP4_FxxP_1 | 306 | 309 | PF00568 | 0.526 |
DOC_PP4_FxxP_1 | 71 | 74 | PF00568 | 0.339 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.386 |
DOC_USP7_MATH_1 | 274 | 278 | PF00917 | 0.295 |
DOC_USP7_MATH_1 | 314 | 318 | PF00917 | 0.652 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.366 |
DOC_USP7_UBL2_3 | 155 | 159 | PF12436 | 0.452 |
LIG_14-3-3_CanoR_1 | 10 | 15 | PF00244 | 0.361 |
LIG_14-3-3_CanoR_1 | 110 | 115 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 122 | 126 | PF00244 | 0.452 |
LIG_14-3-3_CanoR_1 | 148 | 158 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 247 | 257 | PF00244 | 0.452 |
LIG_14-3-3_CanoR_1 | 262 | 267 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 350 | 358 | PF00244 | 0.677 |
LIG_AP2alpha_1 | 302 | 306 | PF02296 | 0.543 |
LIG_BRCT_BRCA1_1 | 276 | 280 | PF00533 | 0.259 |
LIG_Clathr_ClatBox_1 | 236 | 240 | PF01394 | 0.339 |
LIG_deltaCOP1_diTrp_1 | 62 | 71 | PF00928 | 0.334 |
LIG_EVH1_1 | 308 | 312 | PF00568 | 0.543 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.304 |
LIG_FHA_1 | 222 | 228 | PF00498 | 0.252 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.320 |
LIG_FHA_2 | 203 | 209 | PF00498 | 0.271 |
LIG_FHA_2 | 217 | 223 | PF00498 | 0.246 |
LIG_FHA_2 | 333 | 339 | PF00498 | 0.612 |
LIG_FHA_2 | 358 | 364 | PF00498 | 0.685 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.473 |
LIG_LIR_Apic_2 | 222 | 228 | PF02991 | 0.252 |
LIG_LIR_Apic_2 | 304 | 309 | PF02991 | 0.543 |
LIG_LIR_Apic_2 | 48 | 53 | PF02991 | 0.413 |
LIG_LIR_Apic_2 | 70 | 74 | PF02991 | 0.350 |
LIG_LIR_Gen_1 | 160 | 169 | PF02991 | 0.463 |
LIG_LIR_Gen_1 | 180 | 189 | PF02991 | 0.120 |
LIG_LIR_Gen_1 | 192 | 202 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 327 | 337 | PF02991 | 0.630 |
LIG_LIR_Gen_1 | 362 | 372 | PF02991 | 0.638 |
LIG_LIR_Gen_1 | 56 | 64 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 88 | 95 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 13 | 17 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 180 | 184 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 192 | 197 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 304 | 308 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 327 | 332 | PF02991 | 0.634 |
LIG_LIR_Nem_3 | 362 | 367 | PF02991 | 0.637 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.398 |
LIG_NRP_CendR_1 | 379 | 381 | PF00754 | 0.578 |
LIG_Pex14_1 | 67 | 71 | PF04695 | 0.337 |
LIG_Pex14_1 | 98 | 102 | PF04695 | 0.252 |
LIG_Pex14_2 | 235 | 239 | PF04695 | 0.304 |
LIG_Pex14_2 | 302 | 306 | PF04695 | 0.519 |
LIG_REV1ctd_RIR_1 | 303 | 308 | PF16727 | 0.490 |
LIG_SH2_CRK | 225 | 229 | PF00017 | 0.337 |
LIG_SH2_NCK_1 | 225 | 229 | PF00017 | 0.452 |
LIG_SH2_NCK_1 | 364 | 368 | PF00017 | 0.694 |
LIG_SH2_PTP2 | 50 | 53 | PF00017 | 0.472 |
LIG_SH2_STAP1 | 203 | 207 | PF00017 | 0.252 |
LIG_SH2_STAP1 | 329 | 333 | PF00017 | 0.645 |
LIG_SH2_STAP1 | 364 | 368 | PF00017 | 0.632 |
LIG_SH2_STAT3 | 6 | 9 | PF00017 | 0.356 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.452 |
LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.356 |
LIG_SH3_3 | 306 | 312 | PF00018 | 0.541 |
LIG_SH3_3 | 320 | 326 | PF00018 | 0.584 |
LIG_SUMO_SIM_anti_2 | 180 | 186 | PF11976 | 0.213 |
LIG_SxIP_EBH_1 | 108 | 122 | PF03271 | 0.339 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.452 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.452 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.322 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.482 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.447 |
MOD_CK2_1 | 202 | 208 | PF00069 | 0.254 |
MOD_CK2_1 | 324 | 330 | PF00069 | 0.559 |
MOD_CK2_1 | 332 | 338 | PF00069 | 0.553 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.359 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.292 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.297 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.275 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.462 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.485 |
MOD_GlcNHglycan | 376 | 379 | PF01048 | 0.542 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.304 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.267 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.638 |
MOD_NEK2_2 | 193 | 198 | PF00069 | 0.304 |
MOD_NEK2_2 | 53 | 58 | PF00069 | 0.376 |
MOD_PIKK_1 | 137 | 143 | PF00454 | 0.440 |
MOD_PK_1 | 262 | 268 | PF00069 | 0.382 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.486 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.408 |
MOD_PKA_2 | 261 | 267 | PF00069 | 0.389 |
MOD_PKA_2 | 351 | 357 | PF00069 | 0.631 |
MOD_Plk_1 | 146 | 152 | PF00069 | 0.452 |
MOD_Plk_1 | 216 | 222 | PF00069 | 0.260 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.359 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.310 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.465 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.478 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.337 |
MOD_Plk_4 | 324 | 330 | PF00069 | 0.568 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.371 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.349 |
MOD_SUMO_rev_2 | 317 | 326 | PF00179 | 0.641 |
MOD_SUMO_rev_2 | 365 | 375 | PF00179 | 0.575 |
TRG_DiLeu_BaEn_2 | 207 | 213 | PF01217 | 0.252 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.463 |
TRG_ENDOCYTIC_2 | 329 | 332 | PF00928 | 0.644 |
TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.633 |
TRG_ER_diArg_1 | 197 | 199 | PF00400 | 0.252 |
TRG_NLS_Bipartite_1 | 155 | 175 | PF00514 | 0.412 |
TRG_Pf-PMV_PEXEL_1 | 156 | 160 | PF00026 | 0.263 |
TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.631 |
TRG_Pf-PMV_PEXEL_1 | 83 | 88 | PF00026 | 0.549 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2Y9 | Leptomonas seymouri | 86% | 84% |
A0A0S4IZY1 | Bodo saltans | 60% | 87% |
A0A1X0NWK5 | Trypanosomatidae | 72% | 95% |
A0A3R7NUU3 | Trypanosoma rangeli | 71% | 85% |
A0A3S7WRQ0 | Leishmania donovani | 90% | 86% |
A4HV25 | Leishmania infantum | 90% | 86% |
D0A7C4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 91% |
E9ANQ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 86% |
Q4QGW4 | Leishmania major | 89% | 100% |
Q5R7D0 | Pongo abelii | 25% | 100% |
Q8N8Q8 | Homo sapiens | 24% | 100% |
Q8VC74 | Mus musculus | 27% | 100% |
V5C1D0 | Trypanosoma cruzi | 74% | 89% |